This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Valorbec Societe En Commandite. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Dilan Boodhai Jaunky: Innovator in Cancer Treatment
Introduction
Dilan Boodhai Jaunky is a notable inventor based in Montréal, Canada. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds.
Latest Patents
Dilan holds a patent for "Thienoisoquinolines and their derivatives for the treatment of cancer." This patent involves fused N-arylsulfonamidyl-thienoisoquinoline compounds, derivatives, and pharmaceutical compositions that inhibit cancer cell growth. The methods and uses outlined in his patent focus on centrosome targeting and microtubule depolymerization, which are crucial in designing effective chemotherapeutic compounds. The various diseases and conditions treated include multiple types of cell cancers and in vitro inhibition.
Career Highlights
Dilan is currently associated with Valorbec Société En Commandite, where he continues to advance his research in cancer therapeutics. His work is characterized by a commitment to developing innovative solutions that address critical health challenges.
Collaborations
Dilan collaborates with esteemed colleagues such as Pasquale Forgione and Alisa Julienne Piekny, contributing to a dynamic research environment focused on cancer treatment.
Conclusion
Dilan Boodhai Jaunky is a dedicated inventor whose work in cancer treatment exemplifies the impact of innovation in healthcare. His contributions are paving the way for new therapeutic options that could significantly improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile